Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization

Completed · Phase 4

Conditions studied: Heart Disease, Myocardial Infarction, Acute Myocardial Infarction

In brief

The PATCAR study has been designed to test the hypothesis that the strategy of pre-hospital use of a "clot busting" (thrombolytic) drug followed with emergent heart catheterization including stenting of the problematic coronary artery, will result in a lower mortality and reduced repeat heart attack rates. Early identifying and treating heart attacks patients prior to the arriving at the hospital, in those patients who qualify for the "clot busting" drugs will lower the size of the heart attack damage. This smaller heart attack will lead to fewer problems with less repeat heart attacks and death in the future.

Key facts

Study ID
NCT00178620
Run by
The University of Texas Health Science Center, Houston
People needed
390
Starts
2003-09-01
Expected to finish
2009-12-01
Last updated by the study team
2023-09-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.